Market Trends of Digestive Health Supplements Industry
Probiotics Are in High Demand
Probiotics are supplements containing live microorganisms intended to maintain or improve the "good" bacteria (normal microflora). Consumers are increasingly becoming aware of their health through multi-channel publicity, which is anticipated to propel the demand for digestive health supplements, especially probiotics. For instance, according to the Ministry of Food and Drug Safety of the Republic of Korea and the National Food Safety Information Service, in 2022, probiotic products took up about 16.7% of the South Korean health functional food market. Moreover, manufacturers are incorporating novel strains in supplements to offer high-quality products with the added benefit of immunity. With the growing incidences of mastitis in breastfeeding women, leading players are offering probiotics specifically for lactating women. For instance, in July 2023, Danone launched a probiotic supplement, Almimama, for breastfeeding women to prevent mastitis.
North America Holds the Largest Market Share
The increasing prevalence of digestive health issues, including irritable bowel syndrome, inflammatory bowel disease (IBD), cholecystitis, and diarrhea among Americans due to a surge in the consumption of fast-food products, is boosting the digestive health supplement market. Moreover, the aging population in Canada is more susceptible to digestive problems. As individuals age, their digestive become less effective, leading to digestive discomfort and nutrient deficiencies. For instance, according to Statistics Canada, in 2018, there were approximately 3.4 million women and 2.9 million men who were seniors aged over 65, while in 2022, there were 3.9 million and 3.3 million, respectively. Besides this, leading players are expanding their product portfolios to gain a competitive advantage. For instance, in September 2023, Kyowa Hakko USA expanded the reach of its IMMUSE™ postbiotic with its product launch in Mexico in partnership with the pharmaceutical manufacturer Quifaest. IMMUSE™ was a Kyowa’s postbiotic that provided immune support. The product was sold at QuifaHealth stores in malls throughout Mexico City.
